A pilot study to assess the efficacy of Tai Chi for Type 1 Diabetes

• Conditions: Type 1 Diabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12616000277448
• Lead Sponsor: The University of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-03-02
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 46

Inclusion Criteria

type 1 diabetes with HbA1c of 7.5 - 10% on stable insulin therapy; aged 18 - 70 years; no health or injury problems that would prevent doing the exercises; able to attend intervention sessions 2 times per week for 12 weeks and 'self-led' training for a further 12 weeks; and living in Brisbane.

Exclusion Criteria

*Contraindications for physical activity. Medical condition which contraindicates participation in physical activity as suggested by the American College of Sports Medicine 2000 (eg unstable angina, uncontrolled blood pressure > 200/110 mmHg, orthostatic hypotension > 20 mmHg, critical aortic stenosis, uncontrolled atrial or ventricular
arrythmia, uncontrolled sinus tachycardia, acute systemic illness or fever, moderate to severe heart failure, 3 degrees AV block, active pericarditis or myocarditis, recent embolism, thrombophlebitis, resting ST segment displacement [>2mm]);
*Mental illness such as diagnosed bipolar disorder, schizophrenia etc (except depression).
*Currently pregnant or intending to become pregnant during the program;
*Existing pregnancy (or is within 3 months postpartum, or planning pregnancy in the next 12 months)
*Serious back, neck or knee problems
*A diagnosis of dementia, malignancy or life threatening disease
*Previous stroke, neurological or orthopaedic condition inhibiting exercise training
*Inability to complete the data collection forms or follow the program instructions

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
*HbA1c (to give an indication of average blood glucose over the preceding 2 - 3<br>months).[Assess at baseline, 12 weeks and 24 weeks. ];*Depressive symptoms using CESD Depression Scale (CESD 10)[Assess at baseline, 12 weeks and 24 weeks. ]